1. Home
  2. ZLAB vs LMAT Comparison

ZLAB vs LMAT Comparison

Compare ZLAB & LMAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Zai Lab Limited

ZLAB

Zai Lab Limited

N/A

Current Price

$17.60

Market Cap

2.0B

Sector

Health Care

ML Signal

N/A

Logo LeMaitre Vascular Inc.

LMAT

LeMaitre Vascular Inc.

HOLD

Current Price

$85.70

Market Cap

1.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ZLAB
LMAT
Founded
2013
1983
Country
China
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
1.9B
IPO Year
2017
2006

Fundamental Metrics

Financial Performance
Metric
ZLAB
LMAT
Price
$17.60
$85.70
Analyst Decision
Buy
Buy
Analyst Count
6
6
Target Price
$57.22
$101.83
AVG Volume (30 Days)
1.0M
211.9K
Earning Date
11-06-2025
11-06-2025
Dividend Yield
N/A
0.94%
EPS Growth
N/A
27.40
EPS
N/A
2.32
Revenue
$441,629,000.00
$240,866,000.00
Revenue This Year
$30.20
$15.17
Revenue Next Year
$34.71
$9.07
P/E Ratio
N/A
$36.62
Revenue Growth
24.14
13.07
52 Week Low
$16.82
$71.42
52 Week High
$44.34
$105.55

Technical Indicators

Market Signals
Indicator
ZLAB
LMAT
Relative Strength Index (RSI) 29.21 54.29
Support Level $16.82 $82.52
Resistance Level $18.29 $87.09
Average True Range (ATR) 0.60 2.49
MACD 0.17 0.38
Stochastic Oscillator 24.41 64.86

Price Performance

Historical Comparison
ZLAB
LMAT

About ZLAB Zai Lab Limited

Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.

About LMAT LeMaitre Vascular Inc.

LeMaitre Vascular Inc manufactures and distributes medical devices for the treatment of peripheral vascular disease. Its products are used during open vascular surgery and address several anatomical areas, such as the carotid, lower extremities, upper extremities, and aorta. The firm's lower extremities product line contributes towards the proportion of revenue, followed by the carotid product line. LeMaitre's surgical devices include angioscopes, balloon catheters, carotid shunts, phlebectomy devices, vascular grafts, vascular patches and vessel closure systems.It has a single operating segment engaged in the development, manufacturing, and marketing of medical devices and implants, as well as the processing and cryopreservation of human tissues for implantation in patients.

Share on Social Networks: